4//SEC Filing
Watson David O. 4
Accession 0000950170-25-034908
CIK 0001492422other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:17 PM ET
Size
9.3 KB
Accession
0000950170-25-034908
Insider Transaction Report
Form 4
Watson David O.
General Counsel
Transactions
- Gift
Common Stock
2025-03-04−6,667→ 0 total(indirect: By Trust) - Gift
Common Stock
2025-03-04+6,667→ 10,000 total(indirect: Indirect Owner (Custodial Account for Son)) - Sale
Common Stock
2025-03-05$25.10/sh−5,569$139,789→ 138,730 total
Holdings
- 70,136(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Reflects the transfer for no value of shares from the Watson Education Trust to a custodial account held by the reporting person for the sole benefit of his minor son on March 4, 2025.
- [F2]The securities are held by the Watson Education Trust, for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Education Trust except to the extent of his pecuniary interest therein.
- [F3]This represents a custodial account held by the reporting person for the sole benefit of his minor son.
- [F4]The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001657719
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:17 PM ET
- Size
- 9.3 KB